Fort Sheridan Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $924K | Sell |
2,076
-352
| -14% | -$157K | 0.13% | 112 |
|
|
2025
Q1 | $1.18M | Buy |
2,428
+4
| +0.2% | +$1.94K | 0.18% | 81 |
|
|
2024
Q4 | $976K | Buy |
2,424
+386
| +19% | +$155K | 0.14% | 105 |
|
|
2024
Q3 | $948K | Buy |
2,038
+11
| +0.5% | +$5.12K | 0.14% | 101 |
|
|
2024
Q2 | $950K | Buy |
2,027
+352
| +21% | +$165K | 0.15% | 93 |
|
|
2024
Q1 | $700K | Buy |
1,675
+107
| +7% | +$44.7K | 0.13% | 105 |
|
|
2023
Q4 | $638K | Sell |
1,568
-300
| -16% | -$122K | 0.13% | 107 |
|
|
2023
Q3 | $650K | Hold |
1,868
| – | – | 0.15% | 102 |
|
|
2023
Q2 | $657K | Hold |
1,868
| – | – | 0.15% | 98 |
|
|
2023
Q1 | $589K | Buy |
1,868
+376
| +25% | +$118K | 0.15% | 101 |
|
|
2022
Q4 | $431K | Hold |
1,492
| – | – | 0.14% | 113 |
|
|
2022
Q3 | $432K | Hold |
1,492
| – | – | 0.15% | 110 |
|
|
2022
Q2 | $421K | Buy |
1,492
+352
| +31% | +$99.3K | 0.14% | 110 |
|
|
2022
Q1 | $298K | Sell |
1,140
-161
| -12% | -$42.1K | 0.09% | 142 |
|
|
2021
Q4 | $286K | Buy |
+1,301
| New | +$286K | 0.08% | 158 |
|
|
2021
Q2 | – | Sell |
-1,151
| Closed | -$247K | – | 192 |
|
|
2021
Q1 | $247K | Sell |
1,151
-689
| -37% | -$148K | 0.1% | 132 |
|
|
2020
Q4 | $435K | Buy |
+1,840
| New | +$435K | 0.21% | 66 |
|
|
2020
Q3 | – | Sell |
-700
| Closed | -$203K | – | 118 |
|
|
2020
Q2 | $203K | Buy |
+700
| New | +$203K | 0.12% | 96 |
|